{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:47:20Z","timestamp":1790765240509,"version":"4.1.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T00:00:00Z","timestamp":1531180800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.00727","type":"journal-article","created":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T07:04:35Z","timestamp":1531206275000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Appropriateness of Cotrimoxazole Prophylactic Therapy Among HIV\/AIDS Patients in Public Hospitals in Eastern Ethiopia: A Retrospective Evaluation of Clinical Practice"],"prefix":"10.3389","volume":"9","author":[{"given":"Mekonnen","family":"Sisay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dida","family":"Bute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dumessa","family":"Edessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getnet","family":"Mengistu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firehiwot","family":"Amare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tigist","family":"Gashaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Temesgen","family":"Bihonegn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,7,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6113.1000665","article-title":"Opportunistic infections among HIV\/AIDS patients taking ante-retroviral therapy at tertiary care hospital in Wolaita zone, southern Ethiopia.","volume":"8","author":"Alemayehu","year":"2017","journal-title":"J. AIDS Clin. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/intqhc\/mzu085","article-title":"Improving rates of cotrimoxazole prophylaxis in resource-limited settings: implementation of a quality improvement approach.","volume":"26","author":"Bardfield","year":"2014","journal-title":"Int. J. Qual. Health Care"},{"key":"B3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1056\/NEJMoa1214901","article-title":"A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa.","volume":"370","author":"Bwakura-Dangarembizi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.2471\/BLT.14.142745","article-title":"Cotrimoxazole prophylaxis and antiretroviral therapy: an observational cohort study in China.","volume":"93","author":"Cheng","year":"2015","journal-title":"Bull. World Health Org."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.2165\/11203800-000000000-00000","article-title":"Efavirenz\/emtricitabine\/tenofovir disoproxil fumarate single-tablet regimen (Atripla\u00ae).","volume":"70","author":"Deeks","year":"2010","journal-title":"Drugs"},{"key":"B6","first-page":"343","article-title":"Drug use evaluation of cotrimoxazole prophylaxis in people living with human immunodeficiency virus\/acquired immune deficiency syndrome at Jimma University Specialized Hospital, Jimma, South West of Ethiopia, 2013.","volume":"3","author":"Defersha","year":"2014","journal-title":"Int. J. Basic Clin. Pharmacol."},{"key":"B7","first-page":"88","article-title":"Evaluation of the use of cotrimoxazole prophylaxis in people living with HIV\/AIDS in Hawassa referral hospital: a retrospective evaluation.","volume":"1","author":"Deresse","year":"2009","journal-title":"Asian J. Med. Sci."},{"key":"B8","first-page":"59","article-title":"Evaluation of prophylactic use of cotrimoxazole for people living with HIV\/AIDS in Jimma University Specialized Hospital, Southwest Ethiopia.","volume":"18","author":"Diriba","year":"2008","journal-title":"Ethiop. J. Health Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/COH.0000000000000008","article-title":"The 2013 WHO guidelines for antiretroviral therapy: evidence-based recommendations to face new epidemic realities.","volume":"8","author":"Doherty","year":"2013","journal-title":"Curr. Opin. HIV AIDS"},{"key":"B10","year":"2014","journal-title":"Standard Treatment Guidelines for General Hospital"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2147\/HIV.S103081","article-title":"Evaluation of cotrimoxazole use as a preventive therapy among patients living with HIV\/AIDS in Gondar University Referral Hospital, northwestern Ethiopia: a retrospective cross-sectional study.","volume":"8","author":"Gebresillassie","year":"2016","journal-title":"HIV AIDS"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1186\/2050-6511-15-4","article-title":"Retrospective evaluation of cotrimoxazole use as preventive therapy in people living with HIV\/AIDS in Boru Meda Hospital.","volume":"15","author":"Geresu","year":"2014","journal-title":"BMC Pharmacol. Toxicol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1177\/2325957414535976","article-title":"Global policy review of recommendations on cotrimoxazole prophylaxis among people living with HIV.","volume":"13","author":"Gupta","year":"2014","journal-title":"J. Int. Assoc. Provid. AIDS Care"},{"key":"B14","doi-asserted-by":"publisher","first-page":"S257","DOI":"10.1097\/QAI.0000000000000486","article-title":"Assessment of the impact of cotrimoxazole prophylaxis on key outcomes among HIV-infected adults in low-and middle-income countries: a systematic review.","volume":"68","author":"Hassani","year":"2015","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1128\/AAC.01868-13","article-title":"Co-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study.","volume":"58","author":"Hasse","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B16","doi-asserted-by":"publisher","first-page":"390","DOI":"10.2471\/BLT.11.088435","article-title":"The WHO policy package to combat antimicrobial resistance.","volume":"89","author":"Leung","year":"2011","journal-title":"Bull. World Health Org."},{"key":"B17","first-page":"1598","article-title":"Evaluation of prophylactic use of cotrimoxazole for people living with HIV\/AIDS.","volume":"6","author":"Mekonnin","year":"2015","journal-title":"Int. J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2147\/HIV.S79545","article-title":"Magnitude of opportunistic infections and associated factors in HIV-infected adults on antiretroviral therapy in eastern Ethiopia.","volume":"7","author":"Mitiku","year":"2015","journal-title":"HIV AIDS"},{"key":"B19","doi-asserted-by":"crossref","first-page":"172","DOI":"10.11591\/ijphs.v4i3.4729","article-title":"Incidence of opportunistic infections among adult HIV positive people receiving co-trimoxazole prophylaxis.","volume":"4","author":"Tariku","year":"2015","journal-title":"Int. J. Public Health Sci."},{"key":"B20","first-page":"1594","article-title":"Evaluation of cotrimoxazole use in the out patient ward of Seka Chekorsa health center, Jimma zone, Oromia region, Ethiopia.","volume":"5","author":"Tsadik","year":"2015","journal-title":"Indo Am. J. Pharm. Res."},{"key":"B21","year":"1993","journal-title":"How to Investigate Drug use in Health Facilities: Selected Drug Indicators, Action Program on Essential Drugs (DAP), Geneva, 1993"},{"key":"B22","year":"2007","journal-title":"Drug and Therapeutics Committee Training Course. Session 11: Drug Use Evaluation Participant\u2019s Guide"},{"key":"B23","year":"2013","journal-title":"The Use of Co-Trimoxazole Prophylaxis for HIV-Related Infections Among Adults, Adolescents and Children"},{"key":"B24","year":"2014","journal-title":"Guidelines on Post-exposure Prophylaxis for HIV and the Use of Co-Trimoxazole Prophylaxis for HIV-Related Infections Among Adults, Adolescents and Children: Recommendations for a Public Health Approach: December 2014 Supplement to the 2013 Consolidated Guidelines on the use of Antiretroviral Drugs for Treating and Preventing HIV Infection"},{"key":"B25","year":"2016","journal-title":"Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1097\/01.aids.0000180101.80888.c6","article-title":"Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV\/AIDS in C\u00f4te d\u2019Ivoire: a trial-based analysis.","volume":"19","author":"Yazdanpanah","year":"2005","journal-title":"AIDS"},{"key":"B27","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/S1473-3099(07)70239-6","article-title":"Scaling-up co-trimoxazole prophylaxis in HIV-exposed and HIV-infected children in high HIV-prevalence countries.","volume":"7","author":"Zachariah","year":"2007","journal-title":"Lancet Infect. Dis."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.00727\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T17:38:26Z","timestamp":1751737106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.00727\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,10]]},"references-count":27,"alternative-id":["10.3389\/fphar.2018.00727"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.00727","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,10]]},"article-number":"727"}}